Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

503.86
-2.9600-0.58%
Post-market: 503.860.00000.00%16:15 EDT
Volume:439.15K
Turnover:220.90M
Market Cap:21.61B
PE:18.03
High:509.79
Open:502.44
Low:497.91
Close:506.82
52wk High:609.35
52wk Low:395.00
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.66
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.38
PE(LYR):18.09

Loading ...

United Therapeutics Corp - Advance Outcomes Phase 3 Study of Ralinepag in Pah Meets Primary and Secondary Endpoints

THOMSON REUTERS
·
Jul 29

Earning Preview: United Therapeutics Q2 revenue is expected to increase by 0.17%, and institutional views are bullish

Earnings Agent
·
Jul 29

United Therapeutics CEO Martine Rothblatt Reports Sale of 9,500 Common Shares Worth $5.04 Million

Reuters
·
Jul 27

Did a High-Profile Board Addition and ESOP Moves Just Shift United Therapeutics' (UTHR) Investment Narrative?

Simply Wall St.
·
Jul 24

United Therapeutics Director Victor J. Dzau Files Initial Beneficial Ownership Statement

Reuters
·
Jul 24

United Therapeutics CEO Martine A. Rothblatt Disposes of 8,500 Common Shares Worth $4.53 Million

Reuters
·
Jul 24

United Therapeutics Corp - Appoints Victor Dzau to Board of Directors on July 22, 2026

THOMSON REUTERS
·
Jul 23

Press Release: United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026

Dow Jones
·
Jul 22

United Therapeutics Updates Financial Calendar Ahead of Quarterly Results Release, Webcast

Reuters
·
Jul 22

United Therapeutics Chairperson, CEO Martine Rothblatt Reports Sale of 9,500 Shares for $5.03 Million

Reuters
·
Jul 22

Julien Nono-Womdim’s Top Picks for July 21, 2026

Bloomberg
·
Jul 22

United Therapeutics Corp : Leerink Partners Cuts Target Price to $695 from $700

THOMSON REUTERS
·
Jul 21

United Therapeutics CEO Martine Rothblatt Reports $ 4.45 Million Common Share Disposal

Reuters
·
Jul 21

United Therapeutics CEO Martine Rothblatt Reports UTHR Common Share Sale Worth $4.97 Million

Reuters
·
Jul 18

United Therapeutics (UTHR) Stock Still Looks Like A Bargain After A 185% Run

Simply Wall St.
·
Jul 18

United Therapeutics EVP, General Counsel Paul A. Mahon Disposes of Common Shares Worth $3.97 Million

Reuters
·
Jul 17

United Therapeutics CEO Martine Rothblatt Disposes of 9,500 Shares for $5,008,396.54

Reuters
·
Jul 16

United Therapeutics Chairperson, CEO Martine Rothblatt Sells USD 4.89 Million in Common Shares

Reuters
·
Jul 15

United Therapeutics CEO Martine Rothblatt Disposes of USD 3.29 Million in Common Shares

Reuters
·
Jul 14

United Therapeutics Director Jan Malcolm Sells 325 Shares for $178,941.75

Reuters
·
Jul 11